BARTOLONI BOCCI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 12.040
EU - Europa 7.290
AS - Asia 7.250
SA - Sud America 1.494
Continente sconosciuto - Info sul continente non disponibili 811
AF - Africa 211
OC - Oceania 11
Totale 29.107
Nazione #
US - Stati Uniti d'America 11.455
SG - Singapore 3.392
IT - Italia 1.565
IE - Irlanda 1.208
BR - Brasile 1.140
RU - Federazione Russa 1.119
HK - Hong Kong 1.002
CN - Cina 868
FR - Francia 832
VN - Vietnam 769
UA - Ucraina 682
SE - Svezia 577
DE - Germania 376
FI - Finlandia 283
KR - Corea 232
CA - Canada 230
GB - Regno Unito 209
IN - India 199
BD - Bangladesh 170
AR - Argentina 116
IQ - Iraq 73
TR - Turchia 72
NL - Olanda 63
MX - Messico 62
ZA - Sudafrica 62
CO - Colombia 60
AT - Austria 56
EC - Ecuador 55
PL - Polonia 55
CR - Costa Rica 53
CH - Svizzera 51
JP - Giappone 51
ID - Indonesia 50
PK - Pakistan 50
UZ - Uzbekistan 50
TT - Trinidad e Tobago 48
GT - Guatemala 45
VE - Venezuela 45
ES - Italia 43
SA - Arabia Saudita 36
IL - Israele 34
CW - ???statistics.table.value.countryCode.CW??? 32
MA - Marocco 32
PH - Filippine 32
CZ - Repubblica Ceca 31
KE - Kenya 28
JM - Giamaica 25
MY - Malesia 25
NI - Nicaragua 24
LB - Libano 23
SV - El Salvador 23
BE - Belgio 22
CL - Cile 20
HN - Honduras 20
UY - Uruguay 20
EG - Egitto 16
LT - Lituania 16
PR - Porto Rico 16
PY - Paraguay 16
TN - Tunisia 15
AE - Emirati Arabi Uniti 13
AL - Albania 13
OM - Oman 13
PE - Perù 13
RO - Romania 13
GP - Guadalupe 12
GR - Grecia 11
JO - Giordania 11
KZ - Kazakistan 11
NP - Nepal 11
SC - Seychelles 11
DZ - Algeria 10
HU - Ungheria 10
AU - Australia 9
ET - Etiopia 9
PS - Palestinian Territory 9
PT - Portogallo 8
TH - Thailandia 8
EE - Estonia 7
KG - Kirghizistan 7
PA - Panama 7
AZ - Azerbaigian 6
BB - Barbados 6
BG - Bulgaria 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
RS - Serbia 6
EU - Europa 5
MD - Moldavia 5
AO - Angola 4
CY - Cipro 4
KW - Kuwait 4
LV - Lettonia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
LY - Libia 3
MN - Mongolia 3
SI - Slovenia 3
SN - Senegal 3
Totale 28.274
Città #
Singapore 2.298
Dublin 1.201
San Jose 1.158
Chandler 1.138
Ashburn 1.027
Hong Kong 995
San Mateo 641
Council Bluffs 469
Santa Clara 461
Boardman 415
Dong Ket 390
Moscow 370
Lauterbourg 298
Perugia 296
Princeton 286
Medford 283
Altamura 267
Jacksonville 246
Seoul 230
Lawrence 228
Los Angeles 212
Wilmington 212
Beijing 193
Des Moines 184
Andover 155
New York 149
Ho Chi Minh City 121
Munich 118
The Dalles 115
São Paulo 112
Ann Arbor 109
Hanoi 98
Piscataway 87
Helsinki 86
Saint Petersburg 85
Dallas 76
North Bergen 74
Rome 71
Norwalk 69
Milan 65
San Paolo di Civitate 64
Montreal 54
Atlanta 53
Chicago 52
Phoenix 42
Rio de Janeiro 41
San Francisco 41
Brooklyn 40
San José 38
Tokyo 38
Falls Church 37
Frankfurt am Main 37
Buffalo 35
Houston 35
Toronto 35
Charlotte 34
Denver 34
Johannesburg 34
Nuremberg 34
Tashkent 34
Naples 33
Cambridge 32
Orem 32
Willemstad 32
Warsaw 31
Vienna 30
Woodbridge 30
Chennai 29
Baghdad 28
Manchester 28
Shanghai 28
Stockholm 27
Boston 25
Guatemala City 25
Nairobi 25
Belo Horizonte 24
Columbus 23
Mumbai 23
Philadelphia 23
Turku 22
Amsterdam 21
Florence 21
Guayaquil 21
Hefei 21
London 21
Managua 21
Ottawa 21
Brussels 20
Redmond 20
Bologna 19
Porto Alegre 19
Redwood City 19
Ribeirão Preto 19
Riverbank 19
San Salvador 19
Medellín 18
Mexico City 18
Palermo 18
Brasília 17
Chaguanas 17
Totale 16.839
Nome #
Osteoporosi regionale migrante: un caso clinico con dettagliata documentazione RMN. 300
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies 236
Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment 229
Identificazione della lipocaina come nuovo autoantigene nella sindrome di Sjögren primaria. 163
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 153
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 142
Ambiente e malattie reumatiche: il fumo. 139
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 137
Sindrome algodistrofica paraneoplastica: case report e possibile approccio terapeutico. 135
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 133
Classical and autoimmune factors associated with intima-media thickness in rheumatoid arthritis 132
Identification of regulatory T cells in systemic lupus erythematosus 131
Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases. 130
Analisi della correlazione tra distensione della capsula articolare ed ipercarico metatarsale in soggetti con metatarsalgia meccanica. 130
Associazione tra anticorpi anti-citrullina ed aterosclerosi subclinica in una coorte di soggetti affetti da artrite reumatoide. 129
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. 128
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 128
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 125
A Platelet's Guide to Synovitis 125
Isolation and characterization of a new human T regulatory cell subset from peripheral blood CD4+ T lymphocyte 123
CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. 123
2023 International Rome consensus for the nomenclature of Sjögren disease 122
AB0037 CD4+CD25-GITR+regulatory T cells are expanded in the blood, display suppressive function and are inversely correlated with disease activity in patients with primary Sjögren’s syndrome 120
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 120
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 119
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in rheumatoid arthritis patients 119
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New 118
Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody. 116
Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients 115
A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation: Table 1 115
Microbiota and arthritis: cause or consequence? 114
Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system. 114
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? 114
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 113
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 113
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 112
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 112
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 111
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives 111
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 111
Rituximab treatment for persistent scleritis associated with rheumatoid arthritis 110
Policondrite ricorrente e sindrome mieloproliferativa cronica in soggetto con spondilite anchilosante: effetto del trattamento con anti-TNF alpha. 110
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 110
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 108
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. 107
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. 107
Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. 107
Autoimmune hypophysitis 107
Heat shock protein-60 and -65, and anti-oxidized LDL autoantibodies in Sjogren's syndrome 106
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 106
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid Arthritis 106
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 106
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 106
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry 105
Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. 105
Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations. 105
Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment 104
CD4+CD28- lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients 103
Endothelial Microparticles and Circulating Endothelial Progenitor Cells in Primary SjöGren’s Syndrome Patients: Correlation with Clinical and Immunological Features 103
Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity 103
La sclerosi sitemica progressiva 102
Role of regulatory T cells in rheumatoid arthritis: fact and hypothesis 102
Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome. 102
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications. 102
Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study 102
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 102
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 101
L'ipertensione arteriosa polmonare nelle malattie reumatiche 100
“Artrite reumatoide ed altri reumatismi infiammatori cronici: inquadramento attuale” 100
Quantificazione del DNA circolante nelle malattie reumatiche autoimmuni: ipotesi su una possibile correlazione con l’attività di malattia 100
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance? 100
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 100
Recent views on the pathogenesis of cardiovascular damage associated with rheumatoid arthritis 100
Characterisation of articular manifestations in primary Sjögren's syndrome: clinical and imaging features 100
Acro-osteolysis of the big toe in a patient with psoriatic arthritis. 99
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 99
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 99
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. 99
Gli Esami di autoimmunologia nella diagnosi e nel monitoraggio della sclerosi sistemica-il quesito del clinico - 21° Congresso Nazionale SIMEL 98
Associazione tra sindrome di Sjögren primaria e malattia celiaca. 98
Rituximab in primary Sjögren's syndrome: a ten-year journey. 98
Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. 97
AB0191 Clinical significance of multiple autoantibody specificities in rheumatoid arthritis: the role of anti-citrullinated alpha enolase and anti-interferon inducible protein 16 97
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? 97
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 97
Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells 96
Association of subclinical atherosclerosis and leukopenia in systemic autoimmune diseases 96
Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literature 96
A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis 96
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 96
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 96
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 96
JAK inhibitors and autoimmune rheumatic diseases 95
Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link 95
Endothelial microparticles and circulating endothelial progenitor cells in primary Sjögren’s syndrome patients: a potential marker of endothelial damage?. 95
Endothelial microparticles and circulating endothelial progenitor cells in inflammatory rheumatic diseases: effect of anti-inflammatory therapy. 95
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 95
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 95
IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren’s syndrome 95
Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjÖGren's Syndrome: New Markers of Chronic Endothelial Damage? 95
Totale 11.407
Categoria #
all - tutte 138.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.611 0 0 0 0 101 37 43 690 31 60 269 380
2022/20234.081 308 736 36 304 312 523 8 185 1.493 11 126 39
2023/20241.464 112 174 69 43 22 76 294 38 122 45 226 243
2024/20254.408 75 419 79 158 562 179 95 298 1.083 275 824 361
2025/20268.984 744 539 517 1.112 1.099 722 1.612 582 950 714 211 182
2026/20273.807 204 389 612 2.236 366 0 0 0 0 0 0 0
Totale 29.107